{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:02:05Z","timestamp":1789732925617,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI187352"],"award-info":[{"award-number":["1R01AI187352"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI187352"],"award-info":[{"award-number":["1R01AI187352"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI187352"],"award-info":[{"award-number":["1R01AI187352"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI151006-S01"],"award-info":[{"award-number":["1R01AI151006-S01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI151006-S01"],"award-info":[{"award-number":["1R01AI151006-S01"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"United States Department of Defense | United States Army | Army Medical Command | Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["MIDRIP"],"award-info":[{"award-number":["MIDRIP"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Crimean-Congo Hemorrhagic Fever Virus (CCHFV) is a tick-borne virus endemic to Africa, Asia, and expanding regions within Europe. With mortality rates approaching 40%, rising incidence, and no currently approved countermeasures, CCHFV is recognized as a priority public health threat. CCHFV nucleocapsid protein (NP) has long been a key target for diagnostics. Recently, NP-specific humoral responses have also been correlated with protection conferred by protective vaccines candidates. Additionally, the first non-neutralizing monoclonal antibody (mAb) 9D5 demonstrated protective efficacy against CCHFV challenge, underscoring NP as a viable antiviral target. Here, nine anti-NP mAb were utilized to identify four antigenic sites on NP as well as localize these sites to the head or stalk domains. These mAb also revealed variable levels of in vivo protection, independent from whether the epitope site is located in the head or stalk regions. Additionally, three X-ray crystallography structures were obtained that included CCHFV NP from strain Afg09-2990 in complex with the most potent mAb (9D5). This, along with additional structures of two unbound NPs, revealed structural elements critical for mAb-9D5 broad-spectrum protective characteristics. These findings provide a path towards the rapid identification of broadly protective anti-NP mAb countermeasures.<\/jats:p>","DOI":"10.1038\/s41467-026-76702-1","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:35:05Z","timestamp":1787272505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and mechanistic insights into protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus nucleocapsid protein"],"prefix":"10.1038","volume":"17","author":[{"given":"Vanessa","family":"Moresco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-6400","authenticated-orcid":false,"given":"Aura R.","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa A.","family":"Edmundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9891-7727","authenticated-orcid":false,"given":"Collin J.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-8854","authenticated-orcid":false,"given":"Elif","family":"Karaaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Olschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keersten M.","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadara T.","family":"Ogundare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laliv","family":"Tadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-3605","authenticated-orcid":false,"given":"Mohammad M.","family":"Sajadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-8628","authenticated-orcid":false,"given":"\u00c9ric","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-313X","authenticated-orcid":false,"given":"Joseph W.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2958-5319","authenticated-orcid":false,"given":"Scott D.","family":"Pegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"76702_CR1","doi-asserted-by":"crossref","unstructured":"Kuhn, J. H. et al. ICTV virus taxonomy profile: Nairoviridae 2024. J. Gen. Virol. 105, 001974 (2024).","DOI":"10.1099\/jgv.0.002002"},{"key":"76702_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1099\/jgv.0.001485","volume":"101","author":"AR Garrison","year":"2020","unstructured":"Garrison, A. R. et al. ICTV virus taxonomy profile: Nairoviridae. J. Gen. Virol. 101, 798\u2013799 (2020).","journal-title":"J. Gen. Virol."},{"key":"76702_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","volume":"100","author":"DA Bente","year":"2013","unstructured":"Bente, D. A. et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir. Res. 100, 159\u2013189 (2013).","journal-title":"Antivir. Res."},{"key":"76702_CR4","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.3390\/microorganisms9091907","volume":"9","author":"N Shahhosseini","year":"2021","unstructured":"Shahhosseini, N. et al. Crimean-Congo hemorrhagic fever virus in Asia, Africa and Europe. Microorganisms 9, 1907 (2021).","journal-title":"Microorganisms"},{"key":"76702_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","volume":"64","author":"CA Whitehouse","year":"2004","unstructured":"Whitehouse, C. A. Crimean-Congo hemorrhagic fever. Antivir. Res. 64, 145\u2013160 (2004).","journal-title":"Antivir. Res."},{"key":"76702_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","volume":"6","author":"\u00d6 Erg\u00f6n\u00fcl","year":"2006","unstructured":"Erg\u00f6n\u00fcl, \u00d6 Crimean-Congo haemorrhagic fever.  Lancet Infect. Dis. 6, 203\u2013214 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"76702_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/22221751.2021.1936197","volume":"10","author":"YC Wang","year":"2021","unstructured":"Wang, Y. C. et al. A new nairo-like virus associated with human febrile illness in China. Emerg. Microbes Infect. 10, 1200\u20131208 (2021).","journal-title":"Emerg. Microbes Infect."},{"key":"76702_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41591-020-01228-y","volume":"27","author":"J Ma","year":"2021","unstructured":"Ma, J. et al. Identification of a new orthonairovirus associated with human febrile illness in China. Nat. Med. 27, 434\u2013439 (2021).","journal-title":"Nat. Med."},{"key":"76702_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa2313722","volume":"391","author":"XA Zhang","year":"2024","unstructured":"Zhang, X. A. et al. A new orthonairovirus associated with human febrile illness. N. Engl. J. Med. 391, 821\u2013831 (2024).","journal-title":"N. Engl. J. Med."},{"key":"76702_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25857-0","volume":"12","author":"F Kodama","year":"2021","unstructured":"Kodama, F. et al. A novel nairovirus associated with acute febrile illness in Hokkaido, Japan. Nat. Commun. 12, 5539 (2021).","journal-title":"Nat. Commun."},{"key":"76702_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12047-6","volume":"7","author":"J Bouquet","year":"2017","unstructured":"Bouquet, J. et al. Metagenomic-based Surveillance of Pacific Coast tick Dermacentor occidentalis Identifies two novel bunyaviruses and an emerging human ricksettsial pathogen. Sci. Rep. 7, 12234 (2017).","journal-title":"Sci. Rep."},{"key":"76702_CR12","doi-asserted-by":"crossref","unstructured":"Cristina, M. C. et al. Prototype pathogen approach for vaccine and monoclonal antibody development: a critical component of the NIAID plan for pandemic preparedness. J. Infect. Dis. 227, 1433\u20131441 (2022).","DOI":"10.1093\/infdis\/jiac296"},{"key":"76702_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa1615162","volume":"377","author":"A Negredo","year":"2017","unstructured":"Negredo, A. et al. Autochthonous Crimean-Congo hemorrhagic fever in Spain. N. Engl. J. Med. 377, 154\u2013161 (2017).","journal-title":"N. Engl. J. Med."},{"key":"76702_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.coviro.2018.12.002","volume":"34","author":"JR Spengler","year":"2019","unstructured":"Spengler, J. R., Bergeron, \u00c9 & Spiropoulou, C. F. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Curr. Opin. Virol. 34, 70\u201378 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"76702_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3201\/eid3005.231742","volume":"30","author":"P Kiwan","year":"2024","unstructured":"Kiwan, P. et al. Crimean-Congo hemorrhagic fever virus in ticks collected from cattle, Corsica, France, 2023. Emerg. Infect. Dis. 30, 1036\u20131039 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"76702_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3201\/eid2101.141413","volume":"21","author":"NG Conger","year":"2015","unstructured":"Conger, N. G. et al. Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009. Emerg. Infect. Dis. 21, 23\u201331 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"76702_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijid.2017.02.018","volume":"58","author":"Al-Abri SS","year":"2017","unstructured":"SS, A. l-A. bri et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int. J. Infect. Dis. 58, 82\u201389 (2017).","journal-title":"Int. J. Infect. Dis."},{"key":"76702_CR18","doi-asserted-by":"crossref","unstructured":"Mehand, M. S. et al. World Health Organization methodology to prioritize emerging infectious diseases in need of research and development. Emerg. Infect. Dis. J. 24, e171427 (2018).","DOI":"10.3201\/eid2409.171427"},{"key":"76702_CR19","doi-asserted-by":"publisher","first-page":"19504","DOI":"10.2807\/ese.15.10.19504-en","volume":"15","author":"HC Maltezou","year":"2010","unstructured":"Maltezou, H. C. et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Eurosurveillance 15, 19504 (2010).","journal-title":"Eurosurveillance"},{"key":"76702_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3390\/v8040106","volume":"8","author":"M Zivcec","year":"2016","unstructured":"Zivcec, M., Scholte, F. E., Spiropoulou, C. F., Spengler, J. R. & Bergeron, E. Molecular insights into Crimean-Congo hemorrhagic fever virus. Viruses 8, 106 (2016).","journal-title":"Viruses"},{"key":"76702_CR21","doi-asserted-by":"crossref","unstructured":"Papa, A. et al. History and classification of Aigai virus (formerly Crimean-Congo haemorrhagic fever virus genotype VI). J. Gen. Virol. 103, 001734 (2022).","DOI":"10.1099\/jgv.0.001734"},{"key":"76702_CR22","doi-asserted-by":"publisher","first-page":"8834","DOI":"10.1128\/JVI.00752-06","volume":"80","author":"VM Deyde","year":"2006","unstructured":"Deyde, V. M., Khristova, M. L., Rollin, P. E., Ksiazek, T. G. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80, 8834\u20138842 (2006).","journal-title":"J. Virol."},{"key":"76702_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105244","volume":"199","author":"SE Rodriguez","year":"2022","unstructured":"Rodriguez, S. E. et al. Immunobiology of Crimean-Congo hemorrhagic fever. Antivir. Res. 199, 105244 (2022).","journal-title":"Antivir. Res."},{"key":"76702_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2013.12.015","volume":"79","author":"K Ergunay","year":"2014","unstructured":"Ergunay, K. et al. Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: a comprehensive analysis during the early stages of the infection. Diagn. Microbiol. Infect. Dis. 79, 31\u201336 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"76702_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw9535","volume":"5","author":"JW Golden","year":"2019","unstructured":"Golden, J. W. et al. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci. Adv. 5, eaaw9535 (2019).","journal-title":"Sci. Adv."},{"key":"76702_CR26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","volume":"170","author":"JA Horwitz","year":"2017","unstructured":"Horwitz, J. A. et al. Non-neutralizing antibodies alter the course of HIV-1 infection in vivo. Cell 170, 637\u2013648 e610 (2017).","journal-title":"Cell"},{"key":"76702_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/297070a0","volume":"297","author":"AL Schmaljohn","year":"1982","unstructured":"Schmaljohn, A. L., Johnson, E. D., Dalrymple, J. M. & Cole, G. A. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297, 70\u201372 (1982).","journal-title":"Nature"},{"key":"76702_CR28","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","volume":"80","author":"KM Chung","year":"2006","unstructured":"Chung, K. M. et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 80, 1340\u20131351 (2006).","journal-title":"J. Virol."},{"key":"76702_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34923-0","volume":"13","author":"IA Durie","year":"2022","unstructured":"Durie, I. A. et al. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus. Nat. Commun. 13, 7298 (2022).","journal-title":"Nat. Commun."},{"key":"76702_CR30","doi-asserted-by":"publisher","first-page":"e0005908","DOI":"10.1371\/journal.pntd.0005908","volume":"11","author":"AR Garrison","year":"2017","unstructured":"Garrison, A. R. et al. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLoS Negl. Trop. Dis. 11, e0005908 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"76702_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","volume":"6","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nat. Microbiol. 6, 187\u2013195 (2021).","journal-title":"Nat. Microbiol."},{"key":"76702_CR32","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/eji.201343565","volume":"43","author":"T Straub","year":"2013","unstructured":"Straub, T. et al. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcgammaR. Eur. J. Immunol. 43, 2338\u20132348 (2013).","journal-title":"Eur. J. Immunol."},{"key":"76702_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06741-w","volume":"9","author":"T Abreu-Mota","year":"2018","unstructured":"Abreu-Mota, T. et al. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat. Commun. 9, 4223 (2018).","journal-title":"Nat. Commun."},{"key":"76702_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1099\/jgv.0.000011","volume":"96","author":"H Karlberg","year":"2015","unstructured":"Karlberg, H., Tan, Y. J. & Mirazimi, A. Crimean-Congo haemorrhagic fever replication interplays with regulation mechanisms of apoptosis. J. Gen. Virol. 96, 538\u2013546 (2015).","journal-title":"J. Gen. Virol."},{"key":"76702_CR35","doi-asserted-by":"publisher","first-page":"12294","DOI":"10.1128\/JVI.01627-12","volume":"86","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. J. Virol. 86, 12294\u201312303 (2012).","journal-title":"J. Virol."},{"key":"76702_CR36","doi-asserted-by":"crossref","unstructured":"Hawman, D. W. & Feldmann, H. Crimean-Congo haemorrhagic fever virus. Nat. Rev. Microbiol. 21, 463\u2013477 (2023).","DOI":"10.1038\/s41579-023-00871-9"},{"key":"76702_CR37","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","unstructured":"Bertolotti-Ciarlet, A. et al. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 79, 6152\u20136161 (2005).","journal-title":"J. Virol."},{"key":"76702_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/S0950268800057277","volume":"111","author":"FJ Burt","year":"1993","unstructured":"Burt, F. J., Swanepoel, R. & Braack, L. E. O. Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol. Infect. 111, 547\u2013558 (1993).","journal-title":"Epidemiol. Infect."},{"key":"76702_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00877-1","volume":"9","author":"TE Sorvillo","year":"2024","unstructured":"Sorvillo, T. E. et al. Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus. NPJ Vaccines 9, 88 (2024).","journal-title":"NPJ Vaccines"},{"key":"76702_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","volume":"8","author":"FEM Scholte","year":"2019","unstructured":"Scholte, F. E. M. et al. Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice. Emerg. Microbes Infect. 8, 575\u2013578 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"76702_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105090","volume":"191","author":"JR Spengler","year":"2021","unstructured":"Spengler, J. R. et al. Viral replicon particles protect IFNAR(-\/-) mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination. Antivir. Res. 191, 105090 (2021).","journal-title":"Antivir. Res."},{"key":"76702_CR42","doi-asserted-by":"publisher","first-page":"e0006628","DOI":"10.1371\/journal.pntd.0006628","volume":"12","author":"M Zivcec","year":"2018","unstructured":"Zivcec, M., Safronetz, D., Scott, D. P., Robertson, S. & Feldmann, H. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge. PLoS Negl. Trop. Dis. 12, e0006628 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"76702_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104188","volume":"82","author":"SS Leventhal","year":"2022","unstructured":"Leventhal, S. S. et al. Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. EBioMedicine 82, 104188 (2022).","journal-title":"EBioMedicine"},{"key":"76702_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53362-7","volume":"15","author":"SS Leventhal","year":"2024","unstructured":"Leventhal, S. S. et al. Antibodies targeting the Crimean-Congo hemorrhagic fever virus nucleoprotein protect via TRIM21. Nat. Commun. 15, 9236 (2024).","journal-title":"Nat. Commun."},{"key":"76702_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46110-4","volume":"15","author":"AR Garrison","year":"2024","unstructured":"Garrison, A. R. et al. Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus. Nat. Commun. 15, 1722 (2024).","journal-title":"Nat. Commun."},{"key":"76702_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01293-9","volume":"10","author":"TE Sorvillo","year":"2025","unstructured":"Sorvillo, T. E. et al. Durable humoral immunity and long-term protection induced by a Crimean-Congo hemorrhagic fever virus replicon particle vaccine in mice. NPJ Vaccines 10, 244 (2025).","journal-title":"NPJ Vaccines"},{"key":"76702_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104573","volume":"170","author":"JR Spengler","year":"2019","unstructured":"Spengler, J. R. et al. Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine. Antivir. Res. 170, 104573 (2019).","journal-title":"Antivir. Res."},{"key":"76702_CR48","doi-asserted-by":"publisher","first-page":"11740","DOI":"10.1128\/JVI.01680-15","volume":"89","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. Structural and functional diversity of nairovirus-encoded nucleoproteins. J. Virol. 89, 11740\u201311749 (2015).","journal-title":"J. Virol."},{"key":"76702_CR49","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1128\/JVI.01555-12","volume":"86","author":"SD Carter","year":"2012","unstructured":"Carter, S. D. et al. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Virol. 86, 10914\u201310923 (2012).","journal-title":"J. Virol."},{"key":"76702_CR50","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1073\/pnas.1200808109","volume":"109","author":"Y Guo","year":"2012","unstructured":"Guo, Y. et al. Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc. Natl. Acad. Sci. USA 109, 5046\u20135051 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76702_CR51","doi-asserted-by":"crossref","unstructured":"Mishra, A. K. et al. Structure and characterization of Crimean-Congo hemorrhagic fever virus GP38. J. Virol. 94, e02005-19 (2020).","DOI":"10.1128\/JVI.02005-19"},{"key":"76702_CR52","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","volume":"184","author":"JM Fels","year":"2021","unstructured":"Fels, J. M. et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell 184, 3486\u20133501.e3421 (2021).","journal-title":"Cell"},{"key":"76702_CR53","doi-asserted-by":"crossref","unstructured":"Zivcec, M. et al. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. Antivir. Res. 146, 112\u2013120 (2017).","DOI":"10.1016\/j.antiviral.2017.08.014"},{"key":"76702_CR54","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","volume":"181","author":"DM Carragher","year":"2008","unstructured":"Carragher, D. M., Kaminski, D. A., Moquin, A., Hartson, L. & Randall, T. D. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181, 4168\u20134176 (2008).","journal-title":"J. Immunol."},{"key":"76702_CR55","doi-asserted-by":"crossref","unstructured":"\u0160antak, M. & Mati\u0107, Z. The role of nucleoprotein in immunity to human negative-stranded RNA viruses-not just another brick in the viral nucleocapsid. Viruses 14, 521 (2022).","DOI":"10.3390\/v14030521"},{"key":"76702_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01646-22","volume":"97","author":"WF Rijnink","year":"2023","unstructured":"Rijnink, W. F. et al. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. J. Virol. 97, e0164622 (2023).","journal-title":"J. Virol."},{"key":"76702_CR57","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ymthe.2022.09.016","volume":"31","author":"DW Hawman","year":"2023","unstructured":"Hawman, D. W. et al. Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Mol. Ther. 31, 387\u2013397 (2023).","journal-title":"Mol. Ther."},{"key":"76702_CR58","doi-asserted-by":"publisher","first-page":"e108419","DOI":"10.1371\/journal.pone.0108419","volume":"9","author":"D Liu","year":"2014","unstructured":"Liu, D. et al. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV). PLoS ONE 9, e108419 (2014).","journal-title":"PLoS ONE"},{"key":"76702_CR59","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jviromet.2013.07.055","volume":"193","author":"FJ Burt","year":"2013","unstructured":"Burt, F. J. et al. Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach. J. Virol. Methods 193, 706\u2013712 (2013).","journal-title":"J. Virol. Methods"},{"key":"76702_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12250-010-3067-7","volume":"25","author":"P-f Wei","year":"2010","unstructured":"Wei, P. -f et al. Serial expression of the truncated fragments of the nucleocapsid protein of CCHFV and identification of the epitope region. Virologica Sin. 25, 45\u201351 (2010).","journal-title":"Virologica Sin."},{"key":"76702_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105857","volume":"118","author":"E Karaaslan","year":"2025","unstructured":"Karaaslan, E. et al. Rapid, sensitive, and species-independent detection of Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 antibodies. EBioMedicine 118, 105857 (2025).","journal-title":"EBioMedicine"},{"key":"76702_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114502","volume":"43","author":"OS Shin","year":"2024","unstructured":"Shin, O. S. et al. Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Rep. 43, 114502 (2024).","journal-title":"Cell Rep."},{"key":"76702_CR63","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.mib.2011.07.011","volume":"14","author":"RW Ruigrok","year":"2011","unstructured":"Ruigrok, R. W., Cr\u00e9pin, T. & Kolakofsky, D. Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr. Opin. Microbiol. 14, 504\u2013510 (2011).","journal-title":"Curr. Opin. Microbiol."},{"key":"76702_CR64","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/JVI.02070-06","volume":"81","author":"A-M Connolly-Andersen","year":"2007","unstructured":"Connolly-Andersen, A.-M., Magnusson, K.-E. & Mirazimi, A. Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 81, 2158\u20132164 (2007).","journal-title":"J. Virol."},{"key":"76702_CR65","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jsb.2016.09.013","volume":"196","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Molecular basis for the formation of ribonucleoprotein complex of Crimean-Congo hemorrhagic fever virus. J. Struct. Biol. 196, 455\u2013465 (2016).","journal-title":"J. Struct. Biol."},{"key":"76702_CR66","doi-asserted-by":"publisher","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","volume":"11","author":"AJ Shepherd","year":"1989","unstructured":"Shepherd, A. J., Swanepoel, R. & Leman, P. A. Antibody response in Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11, S801\u2013S806 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"76702_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106282","volume":"243","author":"JJ Suschak","year":"2025","unstructured":"Suschak, J. J. et al. CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques. Antivir. Res. 243, 106282 (2025).","journal-title":"Antivir. Res."},{"key":"76702_CR68","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3201\/eid3008.240036","volume":"30","author":"M Metanat","year":"2024","unstructured":"Metanat, M. et al. Crimean-Congo hemorrhagic fever virus kinetics in serum, saliva, and urine, Iran, 2018. Emerg. Infect. Dis. 30, 1706\u20131709 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"76702_CR69","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3389\/fimmu.2019.02049","volume":"10","author":"S Foss","year":"2019","unstructured":"Foss, S. et al. TRIM21-from intracellular immunity to therapy. Front. Immunol. 10, 2049 (2019).","journal-title":"Front. Immunol."},{"key":"76702_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/ni.2548","volume":"14","author":"WA McEwan","year":"2013","unstructured":"McEwan, W. A. et al. Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21. Nat. Immunol. 14, 327\u2013336 (2013).","journal-title":"Nat. Immunol."},{"key":"76702_CR71","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106228","volume":"40","author":"SL Caddy","year":"2021","unstructured":"Caddy, S. L. et al. Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity. EMBO J. 40, e106228 (2021).","journal-title":"EMBO J."},{"key":"76702_CR72","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery, D. L. et al. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc. Natl. Acad. Sci. USA 107, 19985\u201319990 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76702_CR73","unstructured":"National Research Council. Committee for the Update of the Guide for the C, Use of Laboratory A. The National Academies Collection: Reports funded by National Institutes of Health. In Guide for the Care and Use of Laboratory Animals (National Academies Press (US), 2011)."},{"key":"76702_CR74","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U M\u00fcller","year":"1994","unstructured":"M\u00fcller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921 (1994).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76702-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76702-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76702-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:02:41Z","timestamp":1789729361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76702-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76702"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76702-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.R.G. and J.W.G. have a provisional patent application regarding NP-targeting antibodies (9D5 and 21B11) and their use to protect against CCHFV infection, \u201cIdentification and use of nucleocapsid protein targeting molecules that protect animals against Crimean-Congo hemorrhagic fever virus\u201d, United States provisional patent application 63\/421,704 filed 22 Nov 2022. The remaining authors declare no competing interests. The opinions, interpretations, conclusions, and recommendations presented are those of the author and are not necessarily endorsed by the U.S. Army or Department of Defense. C.J.F. and B.D.C. are contractors. This does not constitute an endorsement by the U.S. Government of this or any other contractor. The use of either trade or manufacturers\u2019 names in this report does not constitute an official endorsement of any commercial products. This report may not be cited for the purposes of advertisement.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9967"}}